Summary of Product Characteristics
last updated on the eMC:
05/08/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 05/08/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 4.7 - Effects on Ability to Drive and Use Machines
-
Change to section 4.8 - Undesirable Effects
-
Change to section 4.9 - Overdose
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 5.3 - Preclinical Safety Data
-
Change to section 6. 3 - Shelf Life
-
Change to section 6. 6 - Instructions for use, handling and disposal
-
Change to section 10 date of revision of the text
-
Change to section 1 -Name of the Medicinal product
-
Change to section 2 - Qualitative and quantitative composition
-
Change to section 4.3 - Contraindications
|
|
Updated on 26/04/2004 and displayed until 05/08/2010
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 12/07/2001 and displayed until 26/04/2004
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 22/06/2001 and displayed until 12/07/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 22/06/2001
|
Reasons for adding or updating:
|
|
|
|
